Representation Inquiries

MHS Pharma is a manufacturers’ representative firm selling capital process equipment to pharmaceutical manufacturers, CDMOs, and engineering firms across the Northeast and Mid-Atlantic United States. This page is for equipment manufacturers evaluating sales representation in our territory.

Territory

Our core coverage is twelve states: New Hampshire, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, Pennsylvania, Delaware, Maryland, Virginia, North Carolina, and South Carolina. This footprint includes the densest concentration of pharmaceutical manufacturing, CDMO, and biotech process development sites in the United States. Territory is defined individually in each principal agreement, and our project work regularly extends beyond these states.

Market access

• Serving pharmaceutical manufacturers in this territory since 1996.
• Project history at sites operated by the world’s ten largest pharmaceutical companies, the major US-based manufacturers, and leading global CDMOs.
• Equally at home below big pharma: project history with hundreds of mid-size and small pharmaceutical companies across the territory.
• Established working relationships with the engineering, process development, and procurement teams who specify and purchase capital equipment.

Current lines

We represent these principals and do not take on lines that compete with them:

Roller compaction and dry granulation	Gerteis
Powder transfer, containment, and aseptic filling	DEC Group
Split butterfly valves and aseptic transfer	ChargePoint Technology
Drug substance processing: reactors, filters, dryers	3V Tech
Sieving and filtration	Russell Finex
Milling and sizing	Frewitt
CIP, SIP, and COP cleaning systems	McFlusion
Blending, lifting, and material handling	CDM

Categories of interest

We are open to conversations with manufacturers of equipment adjacent to our current lines. In solid dose, our interests include tablet compression, tablet coating, capsule filling, and compaction simulators. In drug substance: centrifuges, and preparative and process-scale chromatography. In aseptic processing: lyophilizers, vial washing and depyrogenation, automated visual inspection, and container closure integrity testing. In bioprocessing: single-use technologies such as bioreactors, mixing systems, and tangential flow filtration. We do not take on equipment that competes with our current principals.

How we work

We sell technically. Capital equipment purchases in pharmaceutical manufacturing run long cycles through engineering, process development, quality, and procurement, and we work those projects from early specification through installation alongside our principals’ teams.